Perigon Wealth Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,537
| Closed | -$373K | – | 1091 |
|
|
2024
Q3 | $373K | Buy |
16,537
+3,784
| +30% | +$85.4K | 0.01% | 702 |
|
|
2024
Q2 | $248K | Sell |
12,753
-1,415
| -10% | -$27.5K | 0.01% | 754 |
|
|
2024
Q1 | $532K | Buy |
14,168
+4,512
| +47% | +$169K | 0.02% | 516 |
|
|
2023
Q4 | $540K | Buy |
9,656
+1,818
| +23% | +$102K | 0.02% | 475 |
|
|
2023
Q3 | $323K | Sell |
7,838
-2,593
| -25% | -$107K | 0.01% | 559 |
|
|
2023
Q2 | $582K | Buy |
10,431
+81
| +0.8% | +$4.52K | 0.02% | 421 |
|
|
2023
Q1 | $577K | Buy |
10,350
+140
| +1% | +$7.81K | 0.03% | 369 |
|
|
2022
Q4 | $372K | Buy |
10,210
+3,044
| +42% | +$111K | 0.02% | 464 |
|
|
2022
Q3 | $204K | Buy |
7,166
+408
| +6% | +$11.6K | 0.02% | 543 |
|
|
2022
Q2 | $306K | Buy |
6,758
+1,541
| +30% | +$69.8K | 0.03% | 426 |
|
|
2022
Q1 | $397K | Buy |
5,217
+1,331
| +34% | +$101K | 0.03% | 406 |
|
|
2021
Q4 | $579K | Buy |
3,886
+1,600
| +70% | +$238K | 0.04% | 308 |
|
|
2021
Q3 | $333K | Buy |
2,286
+109
| +5% | +$15.9K | 0.03% | 390 |
|
|
2021
Q2 | $426K | Buy |
2,177
+28
| +1% | +$5.48K | 0.04% | 339 |
|
|
2021
Q1 | $389K | Buy |
2,149
+670
| +45% | +$121K | 0.04% | 340 |
|
|
2020
Q4 | $209K | Buy |
+1,479
| New | +$209K | 0.02% | 383 |
|